July 01, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
PHILADELPHIA — Body composition and obesity-related complications differ between men and women, but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME Conference.
July 01, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Metabolic health is a central concept in obesity medicine, yet it is often misunderstood or reduced to weight alone.For…

ACP has published living clinical guidance to help physicians select medications for patients with overweight or…

NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for…

PHILADELPHIA — Wide gaps exist in the prevalence, awareness and treatment of many cardiometabolic conditions, and policies that…

Collecting BMI data could further research into why women with lung cancer have better survival outcomes than men.An evaluation…

WASHINGTON — GLP-1 receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide agonists are not likely to…